Immediate and Long-Term Effects of Different Montages of Transcranial Direct Current Stimulation Over Primary Visual Cortex in Patients With Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial
Abstract
Background: We evaluated the immediate and long-term therapeutic efficacy of transcranial direct current stimulation (tDCS) using two distinct montages of anodal and cathodal electrical stimulation over the primary visual cortex compared with a sham tDCS in patients with chronic migraines.
Methods: In this randomized, double-blind, controlled trial, 72 eligible patients with resistant chronic migraine were randomly assigned to one of three groups, receiving anodal or cathodal (2 mA for 20 min), or sham tDCS (0.5 mA for 30 s), over the pain-dominant side of the primary visual cortex. Clinical features including the number of migraine attacks per month, attack duration, pain intensity, and frequency of painkiller use at baseline, 2 months after starting and ending tDCS therapy were recorded using a personal questionnaire.
Results: Both anodal and cathodal real tDCS protocols resulted in a significant reduction in the number of attacks, pain intensity, attack duration, and frequency of painkiller use during the treatment period compared to baseline. There was no significant difference between the two treatment groups regarding the therapeutic efficacy. However, only anodal tDCS significantly maintained the beneficial therapeutic effects on the number of migraine attacks and painkiller use at the follow-up phase. The sham protocol did not produce any significant clinical utility in this population.
Conclusions: The study supports the analgesic effects of the proposed real tDCS…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 72 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.